Search results for "chagas"

showing 10 items of 47 documents

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Trypanosoma cruzi Parasites

2021

AbstractBackgroundChagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. No progress in the treatment of this pathology has been made since Nifurtimox was introduced more than fifty years ago and is considered very aggressive and may cause several adverse effects. Currently, this drug has severe limitations, including high frequency of undesirable side effects and limited efficacy and availability and the research to discover new drugs for the treatment of Chagas disease is imperative. Many drugs available in the market are natural products as found in nature or compounds designed based on the str…

Chagas diseaseAntiparasiticmedicine.drug_classTrypanosoma cruzi<i>Trypanosoma cruzi</i>Pharmaceutical ScienceParasitemiaPharmacologyTrypanosoma cruzi.Pharmacy and materia medicaDrug DiscoverymedicineCytotoxic T cellStilbene ST18NifurtimoxAmastigoteTrypanosoma cruzibiologyChemistryR<i>Trypanosoma cruzi</i>; stilbene ST18; terphenyl TR4biology.organism_classificationmedicine.diseaseRS1-441TrypanosomaMedicineMolecular MedicineTerphenyl TR4medicine.drugPharmaceuticals
researchProduct

In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic pha…

2012

The in vitro and in vivo anti- Trypanosoma cruzi activity of the pyrazole-containing macrobicyclic polyamine 1 and N-methyl- and N-benzyl-substituted monocyclic polyamines 2 and 3 was studied. Activity against both the acute and chronic phases of Chagas disease was considered. The compounds were more active against the parasite and less toxic against Vero cells than the reference drug benznidazole, but 1 and 2 were especially effective, where cryptand 1 was the most active, particularly in the chronic phase. The activity results found for these compounds were complemented and discussed by considering their inhibitory effect on the iron superoxide dismutase enzyme of the parasite, the nature…

Chagas diseaseCell SurvivalTrypanosoma cruzichemistry.chemical_compoundMiceMicroscopy Electron TransmissionIn vivoDrug DiscoveryChlorocebus aethiopsmedicinePolyaminesAnimalsHumansChagas DiseaseEnzyme InhibitorsTrypanosoma cruziVero Cellschemistry.chemical_classificationMice Inbred BALB CbiologyChemistrySuperoxide Dismutasemedicine.diseasebiology.organism_classificationTrypanocidal AgentsIn vitroEnzymeBiochemistryLiverBenznidazoleVero cellMolecular MedicinePyrazolesFemalePolyaminemedicine.drugJournal of medicinal chemistry
researchProduct

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy.

2018

Background Chagas cardiomyopathy is a serious and common complication of Chagas disease. Methods Through bibliometric and Social Network Analysis, we examined patterns of research on Chagas cardiomyopathy, identifying the main countries, authors, research clusters, and topics addressed; and measuring the contribution of different countries. Results We found 1932 documents on Chagas cardiomyopathy in the MEDLINE database. The most common document type was ‘journal article’, accounting for 79.6% of the total (n = 1538), followed by ‘review’ (n = 217, 11.2%). The number of published records increased from 156 in 1980–1984 to 311 in 2010–2014. Only 2.5% were clinical trials. Brazil and the USA …

Chagas diseaseChagas Cardiomyopathymedicine.medical_specialtyBoliviaLatin AmericansMyocarditislcsh:Arctic medicine. Tropical medicinelcsh:RC955-962MEDLINE030231 tropical medicineMEDLINECardiology030204 cardiovascular system & hematologyBibliometricsResearch and Analysis MethodsGeographical locations03 medical and health sciences0302 clinical medicineMedicine and Health SciencesParasitic DiseasesMedicineHumansChagas DiseaseCooperative BehaviorProtozoan Infectionsbusiness.industryResearchlcsh:Public aspects of medicinePublic Health Environmental and Occupational HealthSocial Supportlcsh:RA1-1270ScientometricsSouth AmericaResearch Assessmentmedicine.diseaseTropical DiseasesResearch PersonnelClinical trialInfectious DiseasesClinical researchBibliometricsFamily medicineCitation AnalysisPeople and placesbusinessCardiomyopathiesBrazilResearch ArticleNeglected Tropical DiseasesPLoS Neglected Tropical Diseases
researchProduct

Computational identification of chemical compounds with potential anti-Chagas activity using a classification tree

2021

Chagas disease is endemic to 21 Latin American countries and is a great public health problem in that region. Current chemotherapy remains unsatisfactory; consequently the need to search for new drugs persists. Here we present a new approach to identify novel compounds with potential anti-chagasic action. A large dataset of 584 compounds, obtained from the Drugs for Neglected Diseases initiative, was selected to develop the computational model. Dragon software was used to calculate the molecular descriptors and WEKA software to obtain the classification tree. The best model shows accuracy greater than 93.4% for the training set; the tree was also validated using a 10-fold cross-validation p…

Chagas diseaseComputer scienceTrypanosoma cruziAntiprotozoal AgentsQuantitative Structure-Activity RelationshipBioengineeringLigandsMachine learningcomputer.software_genre01 natural sciencesConstant false alarm rateSoftwareMolecular descriptorDrug DiscoveryChagas Diseaseclassification treeVirtual screeningMolecular Structure010405 organic chemistrybusiness.industryDecision tree learningGeneral Medicinevirtual screening0104 chemical sciences010404 medicinal & biomolecular chemistryIdentification (information)Tree (data structure)Anti-chagasic actionTest setMolecular MedicineArtificial intelligencebusinesscomputerSoftware
researchProduct

Chagas Disease Vector Control in a Hyperendemic Setting: The First 11 Years of Intervention in Cochabamba, Bolivia

2014

Background Chagas disease has historically been hyperendemic in the Bolivian Department of Cochabamba. In the early 2000s, an extensive vector control program was implemented; 1.34 million dwelling inspections were conducted to ascertain infestation (2000–2001/2003–2011), with blanket insecticide spraying in 2003–2005 and subsequent survey-spraying cycles targeting residual infestation foci. Here, we assess the effects of this program on dwelling infestation rates (DIRs). Methodology/Principal Findings Program records were used to calculate annual, municipality-level aggregate DIRs (39 municipalities); very high values in 2000–2001 (median: 0.77–0.69) dropped to ∼0.03 from 2004 on. A linear…

Chagas diseaseDisease EcologyBolivialcsh:Arctic medicine. Tropical medicineEndemic Diseaseslcsh:RC955-962EpidemiologyEctoparasitic Infestationsmedicine.disease_causeInsect ControlInfectious Disease EpidemiologyOddsInfestationTriatoma infestansparasitic diseasesmedicineMedicine and Health SciencesParasitic DiseasesAnimalsHumansChagas DiseasePublic and Occupational HealthTriatomaEctoparasitic infestationProtozoan InfectionsbiologyEcologylcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratiomedicine.diseasebiology.organism_classificationTropical DiseasesConfidence intervalInfectious DiseasesTriatomaEpidemiological MonitoringDemographyResearch ArticleNeglected Tropical DiseasesPLoS Neglected Tropical Diseases
researchProduct

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region

2019

In the past 5–10 years, Venezuela has faced a severe economic crisis, precipitated by political instability and declining oil revenue. Public health provision has been affected particularly. In this Review, we assess the impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouring countries. Between 2000 and 2015, Venezuela witnessed a 359% increase in malaria cases, followed by a 71% increase in 2017 (411 586 cases) compared with 2016 (240 613). Neighbouring countries, such as Brazil, have reported an escalating trend of imported malaria cases from Venezuela, from 1538 in 2014 to 3129 in 2017. In Venezuela, active Chagas disease transmission has be…

Chagas diseaseDisease transmissionSeroprevalenceReviewmedicine.disease_causeCommunicable Diseases EmergingBOLIVAR STATEZika virusZika virusCHIKUNGUNYADengue0302 clinical medicineInfection preventionINFECTIONSIFONTES030212 general & internal medicineChikungunyaGeography MedicalMAYAROChildSocioeconomicsLeishmaniasisPriority journalArbovirusbiologyTransmission (medicine)Incidence (epidemiology)IncidencePoliticsOilParasite incidenceInfectious DiseasesGeographyVIRUSInfectiongeographic locationsHumanAdultmedicine.medical_specialtyanimal structuresAdolescentCHAGAS-DISEASETrypanosoma cruzi030231 tropical medicineHumanitarian crisisEpidemicVector Borne DiseasesDisease elimination03 medical and health sciencesMALARIAHUMANITARIAN CRISISEPIDEMICparasitic diseasesmedicineSeroprevalenceAnimalsHumansEpidemicsAgedMUNICIPALITYPublic healthDisease re-emergenceNonhumanmedicine.diseasebiology.organism_classificationVenezuelaMalariaEconomic aspectDisease carrierCommunicable Disease ControlChikungunyaMalariaLancet Infectious Diseases
researchProduct

Triatomine vectors of Trypanosoma cruzi: a molecular perspective based on nuclear ribosomal DNA markers.

2002

Chagas disease (American trypanosomiasis) is mainly transmitted by blood-sucking bugs of the reduviid subfamily Triatominae (Hemiptera: Prosorrhyncha). Control strategies are directed mainly against these insect vectors, as no vaccine is available and, except in the very early stage of infection, there is no effective chemotherapy. Studies of deoxyribonucleic acid (DNA) will lead to major advances in our knowledge of Triatominae and their relationships to Chagas disease transmission, epidemiology and control. Analyses of complete sequences of nuclear genes coding for ribosomal ribonucleic acid (rRNA) (rRNA genes) and spacers furnish significant information at the levels of higher taxons, ge…

Chagas diseaseGenetic MarkersNuclear geneTrypanosoma cruzi18S ribosomal RNAPhylogeneticsmedicineAnimalsHumansChagas DiseaseInternal transcribed spacerTriatominaeRibosomal DNAPhylogenyGeneticsbiologyPublic Health Environmental and Occupational HealthGeneral MedicineRibosomal RNAmedicine.diseasebiology.organism_classificationInsect VectorsInfectious DiseasesRNA RibosomalParasitologyTriatominaeTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.

2013

Chagas disease is today one of the most important neglected diseases for its upcoming expansion to non-endemic areas and has become a threat to blood recipients in many countries. In this study, the trypanocidal activity of ten derivatives of a family of aza-scorpiand like macrocycles is evaluated against Trypanosoma cruzi in vitro and in vivo murine model in which the acute and chronic phases of Chagas disease were analyzed. The compounds 4, 3 and 1 were found to be more active against the parasite and less toxic against Vero cells than the reference drug benznidazole, 4 being the most active compound, particularly in the chronic phase. While all these compounds showed a remarkable degree …

Chagas diseaseMacrocyclic CompoundsTrypanosoma cruziAntiprotozoal AgentsLigandsMicrobiologyMiceIn vivoDrug DiscoveryChlorocebus aethiopsmedicineEscherichia coliAnimalsHumansTrypanosoma cruziVero CellsCells CulturedPharmacologychemistry.chemical_classificationAza CompoundsMice Inbred BALB CbiologyMolecular StructureSuperoxide DismutaseOrganic ChemistryGeneral Medicinebiology.organism_classificationmedicine.diseaseIn vitroDisease Models AnimalEnzymechemistryMechanism of actionBenznidazoleImmunologyChronic DiseaseVero cellFemalemedicine.symptommedicine.drugEuropean journal of medicinal chemistry
researchProduct

Application of molecular topology in the prediction of new compounds with anti-trypanosomal cytotoxic activity

2021

La enfermedad de Chagas es una antropozoonosis parasitaria de transmisión mayoritariamente vectorial. Si bien afecta principalmente a América, constituye una de las mayores enfermedades desatendidas a nivel mundial. Solamente dos fármacos con un alto grado de toxicidad se encuentran disponibles para su tratamiento, por lo que es preciso aunar esfuerzos en pos del desarrollo de nuevas drogas antitripanosomales eficaces y con escasos efectos adversos. En este estudio, se aplicó la topología molecular para el desarrollo de un modelo QSAR capaz de predecir la actividad citotóxica antitripanosomal de un grupo de 39 compuestos. El modelo desarrollado mediante análisis lineal discriminante permiti…

Chagas diseaseQuantitative structure–activity relationshipComputational biologyBiologyLinear discriminant analysismedicine.diseaseAntiparasiticsAntiparasitariosChagas3209 Farmacología23 QuímicamedicinePotencyMultiple linear regression analysisMolecular topologyNereis. Interdisciplinary Ibero-American Journal of Methods, Modelling and Simulation.
researchProduct

New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases.

2018

Abstract Despite the continuous research effort that has been made in recent years to find ways to treat the potentially life threatening Chagas disease (CD), this remains the third most important infectious disease in Latin America. CD is an important public health problem affecting 6–7 million people. Since the need to search for new drugs for the treatment of DC persists, in this article we present a panel of new polyamines based on the tripodal structure of tris(2-aminomethyl)amine (tren) that can be prepared at low cost with high yields. Moreover, these polyamines present the characteristic of being water-soluble and resistant to the acidic pH values of stomach, which would allow their…

Chagas diseaseTrypanosoma cruziPharmacology01 natural sciencesMicrobodies03 medical and health scienceschemistry.chemical_compoundIn vivoOral administrationDrug DiscoverymedicinePolyaminesAnimalsHumansChagas DiseaseTrypanosoma cruzi030304 developmental biologyPharmacology0303 health sciencesFluorenesbiology010405 organic chemistryOrganic ChemistryGeneral Medicinemedicine.diseasebiology.organism_classificationTrypanocidal Agents0104 chemical scienceschemistrySolubilityInfectious disease (medical specialty)BenznidazoleNitroimidazolesDrug DesignToxicityAcute DiseaseChronic DiseasePolyaminemedicine.drugEuropean journal of medicinal chemistry
researchProduct